Contact Molecules for Homologous Proteins | ||||
![]() [Summary Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [SupCon3D] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
2931865 | 365 | 500 | P04439(HLAA_HUMAN) | RecName: Full=HLA class I histocompatibility antigen, A alpha chain;AltName: Full=Human leukocyte antigen A; Short=HLA-A;Flags: Precursor; |
QUERYSEQ |
MAVMAPRTLLLLLSGALALTQTWAGSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGTLRGYYNQSEAGSHTIQIMYGCDVGSDGRFLRGYRQDAYDGKDYIAL NEDLRSWTAADMAAQITKRKWEAAHEAEQLRAYLDGTCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEL SSQPTIPIVGIIAGLVLLGAVITGAVVAAVMWRRKSSDRKGGSYTQAASSDSAQGSDVSLTACKV |
365 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() ![]() |
1-24 | SIGNAL | |
![]() ![]() |
25-365 | CHAIN | /note="HLA class I histocompatibility antigen, A alpha chain" /id="PRO_0000018815" |
![]() ![]() ![]() |
25-308 | TOPO_DOM | /note="Extracellular" |
![]() ![]() ![]() |
309-332 | TRANSMEM | /note="Helical" |
![]() ![]() |
333-365 | TOPO_DOM | /note="Cytoplasmic" |
![]() ![]() ![]() |
209-295 | DOMAIN | /note="Ig-like C1-type" |
![]() ![]() ![]() |
3-11 | REGION | /note="VL9 epitope" |
![]() ![]() ![]() |
25-114 | REGION | /note="Alpha-1" |
![]() ![]() ![]() |
115-206 | REGION | /note="Alpha-2" |
![]() ![]() ![]() |
207-298 | REGION | /note="Alpha-3" |
![]() ![]() ![]() |
299-308 | REGION | /note="Connecting peptide" |
![]() ![]() |
339-365 | REGION | /note="Disordered" |
![]() ![]() ![]() |
341-359 | COMPBIAS | /note="Polar residues" |
![]() ![]() ![]() |
31-31 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
97-97 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
108-108 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
140-140 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" |
![]() ![]() ![]() |
167-167 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
170-170 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="2" /ligand_note="self-peptide antigen" |
![]() ![]() ![]() |
195-195 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_label="1" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-365 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
365 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.6 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.6 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 97.5 | F6IQY1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 97.5 | MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.5 | 1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.5 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A6M6CC39_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | F6IQY1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.4 | MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.4 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | 1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 97.4 | A0A583ZB34_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.7 | U5YJJ6_HUMAN MHC class I antigen (Fragment) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 97.4 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 97.4 | Q5S3G3_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*02:01 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.7 | HLA-A*3001 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*3003 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*3003 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 96.0 | HLA-A*3003 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 94.2 | B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.2 | B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.2 | 1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 94.5 | 1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.5 | 1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.2 | 1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.2 | 1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMERA | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 92.8 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.1 | 1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-Aw68) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 94.1 | 1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68.1) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN PROTEIN (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 B* 3501 ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A*0201 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A*0201 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A2*0201 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | 93.1 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
YA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
SA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EB | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A*0201 heavy chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-A0201 ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | HLA-A*02:01 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A2.1 HEAVY CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A2.1 HEAVY CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-A0201 ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | U5YKE0_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A*0201 heavy chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A*0201 heavy chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CB | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AB | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A2*0201 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | U5YJM1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | U5YJM1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA-A 0201 | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | U5YJM1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | U5YJM1_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA-A*0201 heavy chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA-A*02:01 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | U5YKE0_HUMAN MHC class I antigen alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | 93.1 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | HLAA_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 93.1 | U5YKE0_HUMAN MHC class I antigen alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 92.4 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 92.8 | Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 92.4 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | A0A5H2UU57_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 92.4 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (ALPHA CHAIN) | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5H2UU57_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q53Z42_HUMAN HLA class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q8WLS4_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q861F7_HUMAN HLA class I histocompatibility antigen, A alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | A0A5B8RNS7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | Q861F7_HUMAN MHC class I antigen | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 93.1 | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha chain | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 93.1 | Q8WLS4_HUMAN MHC class I antigen | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NEF_HV1Z6 Negative factor[10 aa] | A | 89.3 /97.5 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NEF_HV1Z6 Negative factor[10 aa] | D | 86.2 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YYU8_9HIV1 Nef73 peptide from Protein Nef[10 aa] | A | 100.0 /100.0 |
24 /24 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MYPR_HUMAN MYELIN PROTEOLIPID PROTEIN[9 aa] | A | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | D30 TCR beta chain[244 aa] | A | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | D30 TCR beta chain[244 aa] | F | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | D30 TCR beta chain[244 aa] | A | 100.0 /97.4 |
8 /8 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | D30 TCR beta chain[244 aa] | F | 100.0 /97.4 |
10 /10 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 6-11 T cell receptor beta chain[243 aa] | A | 100.0 /93.1 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 6-11 T cell receptor beta chain[243 aa] | F | 100.0 /93.1 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | 6-11 T cell receptor beta chain[243 aa] | K | 100.0 /93.1 |
7 /7 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | 6-11 T cell receptor beta chain[243 aa] | P | 100.0 /93.1 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor, beta chain[237 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[364 aa] | D | 100.0 /100.0 |
11 /11 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[365 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[364 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN wild-type PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
24 /24 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
28 /28 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN Mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PK3CA_HUMAN Mutant PIK3CA peptide[9 aa] | A | 100.0 /100.0 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor, alpha chain[187 aa] | A | 100.0 /100.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T cell receptor, beta chain[247 aa] | A | 100.0 /100.0 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBAC Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 87.0 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | J | 85.7 /97.5 |
28 /28 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 88.9 /97.4 |
27 /27 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa] | A | 100.0 /100.0 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[348 aa] | D | 100.0 /100.0 |
26 /26 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | PDIA3_HUMAN Protein disulfide-isomerase A3[459 aa] | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T cell receptor, alpha chain[185 aa] | A | 100.0 /100.0 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IgG, Fab Heavy Chain V2[216 aa] | D | 100.0 /100.0 |
16 /16 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | KRAS G12V (7-16)[10 aa] | D | 100.0 /100.0 |
19 /19 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IgG, Fab Light Chain V2[214 aa] | D | 100.0 /100.0 |
8 /8 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_I46A1 Nucleoprotein peptide[9 aa] | A | 100.0 /100.0 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NCAP_I46A1 Nucleoprotein peptide[9 aa] | D | 100.0 /100.0 |
31 /31 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 100.0 /99.6 |
22 /22 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 88.0 /97.5 |
25 /25 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | A | 76.9 /97.5 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | C | 76.9 /97.5 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Heavy chain[216 aa] | A | 100.0 /97.4 |
10 /10 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Heavy chain[216 aa] | E | 100.0 /97.5 |
9 /9 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Light chain[216 aa] | A | 75.0 /97.4 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Light chain[215 aa] | E | 75.0 /97.5 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[181 aa] | A | 91.7 /97.5 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | A | 84.6 /97.5 |
26 /26 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | D | 86.7 /97.5 |
30 /30 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.5 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 86.7 /97.5 |
30 /30 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | SPIKE_SARS2 Spike protein S2' [10 aa] | C | 84.6 /97.5 |
26 /26 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | SPIKE_SARS2 Spike protein S2' [10 aa] | E | 85.7 /97.5 |
28 /28 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[98 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2 MICROGLOBULIN[99 aa] | A | 96.6 /93.1 |
29 /29 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA-A2*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA-A2*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA-A*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA-A*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN (LIGHT CHAIN)[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[99 aa] | A | 93.3 /94.1 |
30 /30 |
1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68.1) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN PROTEIN (BETA 2-MICROGLOBULIN)[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN PROTEIN (BETA 2-MICROGLOBULIN)[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 93.5 /93.1 |
31 /31 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN beta-2-microglobulin[100 aa] | E | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN beta-2-microglobulin[100 aa] | I | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | B2MG_HUMAN beta-2-microglobulin[100 aa] | M | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.6 /93.1 |
37 /37 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[93 aa] | A | 91.2 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.5 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.0 /97.5 |
33 /33 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN PROTEIN (BETA-2-MICROGLOBULIN)[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN PROTEIN (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA-A2.1 HEAVY CHAIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | D | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA-A2.1 HEAVY CHAIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.5 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.2 /97.5 |
36 /36 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.6 /93.1 |
37 /37 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 100.0 /94.5 |
32 /32 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 100.0 /94.5 |
32 /32 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.7 /97.5 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA 2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin, Contains: Beta-2-microglobul.. | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA 2-MICROGLOBULIN[99 aa] | A | 93.8 /94.1 |
32 /32 |
1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-Aw68) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.8 /97.4 |
31 /31 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2 MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 97.1 /93.1 |
35 /35 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[98 aa] | A | 100.0 /100.0 |
29 /29 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
32 /32 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 92.9 /93.1 |
28 /28 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.6 /93.1 |
37 /37 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.7 /93.1 |
38 /38 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.6 /93.1 |
37 /37 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /100.0 |
30 /30 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
30 /30 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
Q53Z42_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /94.2 |
30 /30 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 92.6 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | BA | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | EA | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | HA | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | KA | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | B2MG_HUMAN Beta-2-microglobulin[100 aa] | M | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | NA | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | B2MG_HUMAN Beta-2-microglobulin[100 aa] | P | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | B2MG_HUMAN Beta-2-microglobulin[100 aa] | S | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | B2MG_HUMAN Beta-2-microglobulin[100 aa] | V | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | B2MG_HUMAN Beta-2-microglobulin[100 aa] | Y | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | BA | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | EA | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 92.9 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | HA | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | KA | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | B2MG_HUMAN Beta-2-microglobulin[100 aa] | M | 96.4 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | NA | 92.9 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | B2MG_HUMAN Beta-2-microglobulin[100 aa] | P | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | B2MG_HUMAN Beta-2-microglobulin[100 aa] | S | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | B2MG_HUMAN Beta-2-microglobulin[100 aa] | V | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | B2MG_HUMAN Beta-2-microglobulin[100 aa] | Y | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
29 /29 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 100.0 /94.5 |
31 /31 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[99 aa] | E | 100.0 /94.5 |
30 /30 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 100.0 /94.5 |
33 /33 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[100 aa] | I | 100.0 /94.5 |
29 /29 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | B2MG_HUMAN Beta-2-microglobulin[100 aa] | K | 100.0 /94.5 |
35 /35 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
33 /33 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 100.0 /94.5 |
33 /33 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[99 aa] | E | 100.0 /94.5 |
33 /33 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 100.0 /94.5 |
32 /32 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[100 aa] | I | 100.0 /94.5 |
31 /31 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | B2MG_HUMAN Beta-2-microglobulin[100 aa] | K | 100.0 /94.5 |
32 /32 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[99 aa] | A | 97.0 /97.5 |
33 /33 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN BETA-2-MICROGLOBULIN[99 aa] | C | 97.0 /97.5 |
33 /33 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN BETA-2-MICROGLOBULIN[100 aa] | C | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
33 /33 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
35 /35 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 92.9 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.8 /97.4 |
31 /31 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 90.3 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[100 aa] | B | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.1 /97.4 |
35 /35 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.0 /97.4 |
33 /33 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 97.1 /97.4 |
34 /34 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Beta-2-microglobulin[100 aa] | C | 93.1 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Beta-2-microglobulin[100 aa] | E | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Beta-2-microglobulin[99 aa] | G | 92.9 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
33 /33 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /94.2 |
29 /29 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 92.9 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[99 aa] | E | 97.0 /97.5 |
33 /33 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.1 /96.0 |
29 /29 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.5 /96.7 |
31 /31 |
HLA-A*3001 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /96.0 |
30 /30 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.5 /96.0 |
31 /31 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /94.5 |
29 /29 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BB | B2MG_HUMAN Beta-2-microglobulin[100 aa] | AB | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HB | B2MG_HUMAN Beta-2-microglobulin[100 aa] | BA | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | CA | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DB | B2MG_HUMAN Beta-2-microglobulin[100 aa] | CB | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | EA | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FB | B2MG_HUMAN Beta-2-microglobulin[100 aa] | EB | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | GA | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | IA | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | KA | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | MA | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | OA | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | QA | 96.7 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | SA | 96.7 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | B2MG_HUMAN Beta-2-microglobulin[100 aa] | T | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | UA | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | B2MG_HUMAN Beta-2-microglobulin[100 aa] | V | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
XA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | WA | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | B2MG_HUMAN Beta-2-microglobulin[100 aa] | X | 96.8 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
ZA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | YA | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | B2MG_HUMAN Beta-2-microglobulin[100 aa] | Z | 93.3 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[101 aa] | A | 100.0 /99.6 |
36 /36 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /99.6 |
33 /33 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[97 aa] | A | 93.5 /94.2 |
31 /31 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 94.4 /93.1 |
36 /36 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.8 /93.1 |
32 /32 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 93.9 /93.1 |
33 /33 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 93.3 /93.1 |
30 /30 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[99 aa] | J | 97.1 /93.1 |
35 /35 |
U5YKE0_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 96.8 /93.1 |
31 /31 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
A0A5H2UU57_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 93.8 /93.1 |
32 /32 |
A0A5H2UU57_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 92.9 /92.4 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /92.4 |
30 /30 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /92.4 |
30 /30 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.9 /97.5 |
32 /32 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.1 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /100.0 |
35 /35 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.9 /93.1 |
33 /33 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.1 /93.1 |
34 /34 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 93.3 /93.1 |
30 /30 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.1 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 97.0 /97.4 |
33 /33 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 96.9 /97.5 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.5 |
34 /34 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.1 /97.5 |
35 /35 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 97.0 /97.4 |
33 /33 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.1 /97.4 |
34 /34 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.0 /97.5 |
33 /33 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 96.9 /97.4 |
32 /32 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[97 aa] | F | 96.8 /97.4 |
31 /31 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.5 /93.1 |
31 /31 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | J | 93.8 /93.1 |
32 /32 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 93.9 /93.1 |
33 /33 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | B2MG_HUMAN Beta-2-microglobulin[100 aa] | M | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.9 /93.1 |
33 /33 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
30 /30 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[100 aa] | E | 93.8 /93.1 |
32 /32 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 93.8 /93.1 |
32 /32 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.3 /93.1 |
35 /35 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[100 aa] | E | 94.6 /93.1 |
37 /37 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[100 aa] | F | 93.8 /93.1 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | B2MG_HUMAN Beta-2-microglobulin[100 aa] | K | 94.1 /93.1 |
34 /34 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | B2MG_HUMAN Beta-2-microglobulin[100 aa] | P | 94.1 /93.1 |
34 /34 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.0 /97.5 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.0 /97.4 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.0 /97.5 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 97.0 /97.5 |
33 /33 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 97.1 /97.4 |
34 /34 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /92.8 |
30 /30 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.3 /92.8 |
30 /30 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[101 aa] | D | 100.0 /100.0 |
33 /33 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 94.1 /93.1 |
34 /34 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 93.9 /93.1 |
33 /33 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 93.9 /94.2 |
33 /33 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 93.5 /94.2 |
31 /31 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 93.5 /93.1 |
31 /31 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.6 /93.1 |
37 /37 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /100.0 |
32 /32 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.4 |
32 /32 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 94.6 /93.1 |
37 /37 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[100 aa] | I | 97.0 /93.1 |
33 /33 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[101 aa] | A | 100.0 /100.0 |
34 /34 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.1 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | B2MG_HUMAN Beta-2-microglobulin[100 aa] | G | 93.1 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /96.0 |
28 /28 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[100 aa] | I | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[100 aa] | I | 91.7 /93.1 |
24 /24 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.5 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /96.7 |
32 /32 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | EA | 96.8 /96.7 |
31 /31 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | B2MG_HUMAN Beta-2-microglobulin[99 aa] | F | 96.9 /96.7 |
32 /32 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | JA | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | B2MG_HUMAN Beta-2-microglobulin[99 aa] | K | 96.8 /96.7 |
31 /31 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | OA | 96.9 /96.7 |
32 /32 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | B2MG_HUMAN Beta-2-microglobulin[99 aa] | P | 97.1 /96.7 |
34 /34 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UA | B2MG_HUMAN Beta-2-microglobulin[98 aa] | TA | 96.7 /96.7 |
30 /30 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | B2MG_HUMAN Beta-2-microglobulin[99 aa] | U | 96.8 /96.7 |
31 /31 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | B2MG_HUMAN Beta-2-microglobulin[99 aa] | Z | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 97.0 /96.7 |
33 /33 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 96.8 /97.5 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.9 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 96.4 /97.5 |
28 /28 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | E | 96.9 /97.5 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 96.8 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 96.9 /97.4 |
32 /32 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | B2MG_HUMAN Beta-2-microglobulin[98 aa] | E | 96.4 /97.4 |
28 /28 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.9 /93.1 |
33 /33 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.9 /93.1 |
33 /33 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 93.8 /93.1 |
32 /32 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | B2MG_HUMAN Beta-2-microglobulin[100 aa] | D | 93.8 /93.1 |
32 /32 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[100 aa] | A | 94.1 /93.1 |
34 /34 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[100 aa] | C | 94.1 /93.1 |
34 /34 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | B2MG_HUMAN Beta-2-microglobulin[99 aa] | C | 97.0 /97.4 |
33 /33 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | B2MG_HUMAN Beta-2-microglobulin[99 aa] | H | 97.1 /97.5 |
34 /34 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | B2MG_HUMAN Beta-2-microglobulin[99 aa] | I | 96.9 /97.4 |
32 /32 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | B2MG_HUMAN Beta-2-microglobulin[99 aa] | L | 96.9 /97.4 |
32 /32 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | B2MG_HUMAN Beta-2-microglobulin[99 aa] | O | 96.7 /97.4 |
30 /30 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | B2MG_HUMAN Beta-2-microglobulin[99 aa] | R | 96.8 /97.4 |
31 /31 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_CVHSA SARS NUCLEOCAPSID PEPTIDE[9 aa] | A | 89.7 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LYS-THR-PHE-PRO-PRO-THR-GLU-PRO-LYS[9 aa] | A | 90.0 /97.4 |
30 /30 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA polymerase PEPTIDE HOMOLOGUE[10 aa] | A | 88.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4P6M5_9INFA Nucleocapsid protein[11 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4X2K3_9INFA Nucleoprotein[11 aa] | A | 84.0 /97.4 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2[190 .. | C | 100.0 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | KI2S2_HUMAN Killer cell immunoglobulin-like receptor 2DS2[190 .. | F | 100.0 /97.4 |
12 /12 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A14_VACCW peptide from Virion membrane protein A14[9 aa] | C | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | A14_VACCW peptide from Virion membrane protein A14[9 aa] | F | 87.1 /97.4 |
31 /31 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein 2 epit.. | A | 84.6 /97.4 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 81.8 /97.4 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein-2 epit.. | A | 88.9 /97.4 |
18 /18 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS1 peptide[10 aa] | A | 92.6 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GTS1 peptide[10 aa] | D | 96.2 /97.4 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | GTS1 peptide[10 aa] | G | 89.7 /97.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS1 peptide[10 aa] | A | 89.3 /97.4 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | GTS1 peptide[10 aa] | F | 89.3 /97.4 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS3 peptide[10 aa] | A | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GTS3 peptide[10 aa] | D | 86.7 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | GTS3 peptide[10 aa] | G | 89.7 /97.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS3 peptide[10 aa] | A | 90.0 /97.4 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | GTS3 peptide[10 aa] | F | 89.7 /97.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 75.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | F | 80.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 80.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | F | 83.3 /97.4 |
6 /6 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa] | A | 85.2 /97.4 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR[5 aa] | A | 76.9 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ALA-MET-TYR-LYS[4 aa] | A | 84.6 /97.4 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[7 aa] | D | 91.3 /97.4 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[6 aa] | G | 90.9 /97.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | A | 90.9 /97.5 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | D | 91.3 /97.5 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | G | 87.5 /97.4 |
24 /24 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | J | 90.9 /97.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[191 aa] | A | 91.7 /97.4 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[246 aa] | A | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[245 aa] | A | 100.0 /97.5 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[244 aa] | A | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | TCR beta[244 aa] | F | 100.0 /97.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 88.5 /97.5 |
26 /26 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 89.7 /97.4 |
29 /29 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | F | 89.3 /97.4 |
28 /28 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[163 aa] | A | 90.0 /97.4 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | TCR alpha[179 aa] | F | 90.0 /97.4 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | A | 85.7 /97.5 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | D | 85.7 /97.4 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NS1_INBSJ Non-structural protein 1 peptide RVLVNGTFLK[10 aa].. | A | 87.1 /97.4 |
31 /31 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide KRAS-G12V-9[9 aa] | A | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | peptide KRAS-G12V-9[9 aa] | EA | 85.7 /96.7 |
21 /21 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | peptide KRAS-G12V-9[9 aa] | F | 87.5 /96.7 |
24 /24 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | peptide KRAS-G12V-9[9 aa] | JA | 84.0 /96.7 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | peptide KRAS-G12V-9[9 aa] | K | 86.4 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QA | peptide KRAS-G12V-9[9 aa] | OA | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | peptide KRAS-G12V-9[9 aa] | P | 81.8 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VA | peptide KRAS-G12V-9[9 aa] | TA | 86.4 /96.7 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | peptide KRAS-G12V-9[9 aa] | U | 81.0 /96.7 |
21 /21 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | peptide KRAS-G12V-9[9 aa] | Z | 81.0 /96.7 |
21 /21 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | peptide KRAS-G12V-9[9 aa] | C | 83.3 /96.7 |
24 /24 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | KRAS-G12V nonamer peptide[9 aa] | C | 84.0 /97.4 |
25 /25 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | KRAS-G12V nonamer peptide[9 aa] | H | 85.2 /97.5 |
27 /27 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | KRAS-G12V nonamer peptide[9 aa] | I | 88.0 /97.4 |
25 /25 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | KRAS-G12V nonamer peptide[9 aa] | L | 88.0 /97.4 |
25 /25 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | KRAS-G12V nonamer peptide[9 aa] | O | 88.0 /97.4 |
25 /25 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | KRAS-G12V nonamer peptide[9 aa] | R | 84.6 /97.4 |
26 /26 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T-cell receptor alpha chain[183 aa] | C | 90.9 /97.4 |
11 /11 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | T-cell receptor alpha chain[182 aa] | H | 90.9 /97.5 |
11 /11 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR alpha chain[175 aa] | I | 88.9 /97.4 |
9 /9 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TCR alpha chain[175 aa] | L | 90.0 /97.4 |
10 /10 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR alpha chain[176 aa] | O | 88.9 /97.4 |
9 /9 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | TCR alpha chain[177 aa] | R | 87.5 /97.4 |
8 /8 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[236 aa] | C | 100.0 /97.4 |
9 /9 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | T-cell receptor beta chain[239 aa] | H | 100.0 /97.5 |
12 /12 |
MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR beta chain[239 aa] | I | 100.0 /97.4 |
8 /8 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR beta chain[237 aa] | L | 100.0 /97.4 |
10 /10 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | TCR beta chain[239 aa] | O | 100.0 /97.4 |
9 /9 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | TCR beta chain[238 aa] | R | 100.0 /97.4 |
8 /8 |
A0A6M6CC39_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | SPIKE_SARS2 Spike protein S2' [10 aa] | A | 87.1 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | SPIKE_SARS2 Spike protein S2' [10 aa] | C | 86.7 /97.4 |
30 /30 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | SPIKE_SARS2 Spike protein S2' [10 aa] | E | 87.1 /97.4 |
31 /31 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha chain[198 aa] | A | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA | TCR alpha chain[198 aa] | EA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | TCR alpha chain[198 aa] | F | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MA | TCR alpha chain[198 aa] | JA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | TCR alpha chain[198 aa] | K | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA | TCR alpha chain[198 aa] | OA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | TCR alpha chain[198 aa] | P | 87.5 /96.7 |
8 /8 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WA | TCR alpha chain[198 aa] | TA | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | TCR alpha chain[198 aa] | U | 87.5 /96.7 |
8 /8 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | TCR alpha chain[198 aa] | Z | 88.9 /96.7 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta chain[240 aa] | A | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | TCR beta chain[240 aa] | EA | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | TCR beta chain[240 aa] | F | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA | TCR beta chain[240 aa] | JA | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | TCR beta chain[240 aa] | K | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
SA | TCR beta chain[240 aa] | OA | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | TCR beta chain[240 aa] | P | 100.0 /96.7 |
8 /8 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
XA | TCR beta chain[240 aa] | TA | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | TCR beta chain[240 aa] | U | 100.0 /96.7 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | TCR beta chain[240 aa] | Z | 100.0 /96.7 |
11 /11 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR alpha chain[194 aa] | C | 84.6 /96.7 |
13 /13 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR beta chain[242 aa] | C | 100.0 /96.7 |
7 /7 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS-G12wt-9[9 aa] | A | 88.0 /96.7 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | A | 86.2 /97.5 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | D | 85.7 /97.5 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YV12_9HIV1 RT313 peptide[9 aa] | A | 100.0 /100.0 |
25 /25 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YXY3_9HIV1 9-mer peptide from Pol protein[9 aa] | A | 82.1 /94.2 |
28 /28 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | peptide[9 aa] | A | 85.2 /97.4 |
27 /27 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | peptide[9 aa] | E | 86.2 /97.5 |
29 /29 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RT313[9 aa] | A | 80.0 /96.0 |
25 /25 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ALA-ILE-PHE-GLN-SER-SER-MET-THR-LYS[9 aa] | A | 91.3 /96.7 |
23 /23 |
HLA-A*3001 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 RT[9 aa] | A | 100.0 /96.0 |
22 /22 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | Nucleoprotein[9 aa] | A | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | Nucleoprotein[9 aa] | C | 77.8 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | Nucleoprotein[9 aa] | E | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | Nucleoprotein[9 aa] | G | 80.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | Nucleoprotein[9 aa] | I | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | Nucleoprotein[9 aa] | K | 76.9 /94.5 |
26 /26 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP44[9 aa] | A | 78.6 /96.0 |
28 /28 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | MTB[9 aa] | A | 79.3 /96.0 |
29 /29 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | A | 75.0 /94.5 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | C | 75.0 /94.5 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | E | 73.3 /94.5 |
30 /30 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | G | 75.0 /94.5 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | I | 77.8 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | K | 78.6 /94.5 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAG1_HUMAN MELANOMA-ASSOCIATED ANTIGEN 1[9 aa] | A | 81.5 /94.5 |
27 /27 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MAG1_HUMAN MELANOMA-ASSOCIATED ANTIGEN 1[9 aa] | D | 79.2 /94.5 |
24 /24 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAGA1_HUMAN nonameric peptide from Melanoma-associated antigen.. | A | 76.9 /94.5 |
26 /26 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | HYB3 HEAVY CHAIN[223 aa] | A | 88.9 /94.5 |
9 /9 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | HYB3 HEAVY CHAIN[223 aa] | D | 88.9 /94.5 |
9 /9 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | HYB3 LIGHT CHAIN[210 aa] | A | 100.0 /94.5 |
6 /6 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | HYB3 LIGHT CHAIN[210 aa] | D | 100.0 /94.5 |
5 /5 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR[9 aa] | A | 80.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A0B4J279_HUMAN TCA_HUMAN Protein TRAV21,T-cell receptor alpha chain C regio.. | A | 66.7 /94.5 |
9 /9 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A0B4J279_HUMAN TCA_HUMAN Protein TRAV21,T-cell receptor alpha chain C regio.. | A | 70.0 /94.5 |
10 /10 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A0A578_HUMAN K7N5M4_HUMAN Protein TRBV5-1,Human nkt tcr beta chain[241 aa] | A | 80.0 /94.5 |
5 /5 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A0A578_HUMAN K7N5M4_HUMAN Protein TRBV5-1,Human nkt tcr beta chain[241 aa] | A | 100.0 /94.5 |
4 /4 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TITIN_HUMAN Titin[9 aa] | A | 78.3 /94.5 |
23 /23 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALK[10 aa] | A | 74.1 /94.5 |
27 /27 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | NRAS Q61K peptide[10 aa] | A | 76.0 /94.5 |
25 /25 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CCND2_HUMAN G1/S-specific cyclin-D2[10 aa] | A | 83.9 /94.2 |
31 /31 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 81.5 /94.2 |
27 /27 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | C | 81.5 /94.2 |
27 /27 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | influenza A NP145-156 peptide[7 aa] | A | 79.2 /94.2 |
24 /24 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BOUND PEPTIDE FRAGMENT[3 aa] | A | 75.0 /94.1 |
12 /12 |
1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68.1) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 Spike-derived peptide S976-984 S982A mu.. | A | 82.1 /93.1 |
28 /28 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV REVERSE TRANSCRIPTASE EPITOPE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1MA HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a.. | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | POL_HV1MA HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)[9 a.. | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 POL polyprotein[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1B1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | POL_HV1B1 REVERSE TRANSCRIPTASE/RIBONUCLEASE H[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9WGX1_9HIV1 Polyprotein[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CD8A_HUMAN T-CELL CORECEPTOR CD8[114 aa] | A | 100.0 /93.1 |
13 /13 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CD8A_HUMAN T-CELL CORECEPTOR CD8[114 aa] | A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN MHC CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE P1049 (ALWGFFPVL)[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PEPTIDE P1049 (ALWGFFPVL)[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | self-peptide P1049[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | self-peptide P1049[9 aa] | F | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAX PEPTIDE[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA-A*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HTLV-1 OCTAMERIC TAX PEPTIDE[9 aa] | D | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA-A*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAT_HTL1C NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE.. | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | TAT_HTL1C NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN (RESIDUE.. | D | 84.6 /93.1 |
26 /26 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Human T-cell lymphotropic virus type 1 Tax peptide.. | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Human T-cell lymphotropic virus type 1 Tax peptide.. | E | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | Human T-cell lymphotropic virus type 1 Tax peptide.. | I | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | Human T-cell lymphotropic virus type 1 Tax peptide.. | M | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAX_HTL1F Protein Tax-1[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | TAX_HTL1F Protein Tax-1[9 aa] | D | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAX_HTL1F Protein Tax-1[9 aa] | A | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa] | A | 86.2 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-PHE-GLY-TYR-PRO-VAL-TYR-VAL[9 aa] | D | 84.6 /93.1 |
26 /26 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T CELL RECEPTOR ALPHA[190 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T CELL RECEPTOR BETA[242 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA-A 0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor, beta chain[243 aa] | A | 100.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor, beta chain[243 aa] | A | 75.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A6-Tcr[243 aa] | A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q2YDB4_HUMAN Hypothetical protein[241 aa] | A | 100.0 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q2YDB4_HUMAN Hypothetical protein[242 aa] | A | 100.0 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q6NS87_HUMAN T-Cell Receptor, Beta Chain[242 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A6 TCR beta chain[245 aa] | A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A6 TCR beta chain[245 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q2YDB4_HUMAN TRBV6-5 protein[245 aa] | A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A6 TCR beta chain[245 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A6 beta chain[245 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A6 beta chain[245 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A0A585_HUMAN TRBC1_HUMAN V_segment translation product, T-cell receptor bet.. | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A0A0K0K1A5_HUMAN K7N5M4_HUMAN Protein TRBV6-5,Human nkt tcr beta chain[240 aa] | A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T Cell Receptor Mel8, Beta Chain[245 aa] | A | 100.0 /93.1 |
8 /8 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T Cell Receptor Mel8, Beta Chain[245 aa] | F | 93.8 /93.1 |
16 /16 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Human T Cell Receptor Mel8, Beta Chain[245 aa] | F | 100.0 /93.1 |
10 /10 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa] | A | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA-A2*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HTLV-1 OCTAMERIC TAX PEPTIDE[8 aa] | D | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA-A2*0201 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GP2 PEPTIDE[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GP2 PEPTIDE[9 aa] | D | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GP2 PEPTIDE[9 aa] | A | 88.5 /93.1 |
26 /26 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GP2 PEPTIDE[9 aa] | D | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA-A2.1 MHC CLASS I (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ENV_HV1B8 HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 .. | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | ENV_HV1B8 HIV-1 GP120 ENVELOPE PROTEIN (RESIDUES 195-207)[9 .. | D | 79.2 /93.1 |
24 /24 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CORA_HBVIL HEPATITIS B NUCLEOCAPSID PROTEIN (RESIDUES 18-27)[.. | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_IAPUE INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | M1_IAPUE INFLUENZA A MATRIX PROTEIN M1 (RESIDUES 58-66)[9 a.. | D | 76.9 /93.1 |
26 /26 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A*0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GILGFVFTL[9 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | FLU MATRIX PEPTIDE[9 aa] | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | FLU MATRIX PEPTIDE[9 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | M1_I34A1 Matrix protein 1[9 aa] | C | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | influenza M1 for peptide[9 aa] | A | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Influenza M1(58-66) peptide[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Influenza M1(58-66) peptide[9 aa] | F | 77.3 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU[9 aa] | B | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9.. | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PROTEIN (HIV-RT VARIANT PEPTIDE I1F (FLKEPVHGV))[9.. | D | 80.8 /93.1 |
26 /26 |
1A02_HUMAN PROTEIN (CLASS I HISTOCOMPATIBILITY ANTIGEN, GOGO-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HIV-RT VARIANT PEPTIDE I1Y (YLKEPVHGV)[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAGA4_HUMAN MELANOMA-ASSOCIATED ANTIGEN 4[10 aa] | A | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | MAGA4_HUMAN Melanoma-associated antigen 4[10 aa] | I | 78.3 /93.1 |
23 /23 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | MAGA4_HUMAN Melanoma-associated antigen 4[10 aa] | I | 81.0 /93.1 |
21 /21 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9 RESIDUE PEPTIDE[9 aa] | A | 86.4 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 9 RESIDUE PEPTIDE[9 aa] | D | 85.7 /93.1 |
21 /21 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9 RESIDUE PEPTIDE[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 9 RESIDUE PEPTIDE[9 aa] | D | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9 RESIDUE PEPTIDE[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 9 RESIDUE PEPTIDE[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | US02_HCMVA cytomegalovirus protein US2[95 aa] | A | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | US02_HCMVA cytomegalovirus protein US2[95 aa] | E | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | US02_HCMVA cytomegalovirus protein US2[95 aa] | I | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | US02_HCMVA cytomegalovirus protein US2[95 aa] | M | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-cell Receptor alpha chain[194 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | T-cell Receptor alpha chain[194 aa] | F | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell Receptor beta chain[237 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | T-cell Receptor beta chain[237 aa] | F | 90.9 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-CELL RECEPTOR ALPHA CHAIN V REGION[200 aa] | A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | JM22 TCR ALPHA CHAIN[199 aa] | A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | PF6 TCR alpha chain[191 aa] | C | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | JM22 TCR alpha chain[195 aa] | A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCB_HUMAN T-CELL RECEPTOR BETA CHAIN C REGION[241 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | JM22 TCR BETA CHAIN[240 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | PF6 TCR beta chain[237 aa] | C | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | JM22 TCR beta chain[240 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCRbeta chain[241 aa] | A | 90.9 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCRbeta chain[239 aa] | A | 100.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | TCRbeta chain[239 aa] | F | 100.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SILv44 T cell receptor beta chain[241 aa] | C | 100.0 /93.1 |
9 /9 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SILv44 T cell receptor beta chain[241 aa] | A | 100.0 /93.1 |
9 /9 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T4H2 T cell receptor beta chain[240 aa] | A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T4H2 T cell receptor beta chain[239 aa] | A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T4H2 T cell receptor beta chain[240 aa] | C | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[285 aa] | F | 90.0 /93.1 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | LIRB1_HUMAN leukocyte immunoglobulin-like receptor 1[183 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | LIRB1_HUMAN Leukocyte immunoglobulin-like receptor subfamily B.. | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A0G2JQ44_HUMAN Leukocyte immunoglobulin-like receptor subfamily B.. | A | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | D9IDM8_HUMAN LIR-1[184 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAGA3_HUMAN PROTEIN (MELANOMA-ASSOCIATED ANTIGEN 3)[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN PROTEIN (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ERBB2_HUMAN GP2 PEPTIDE[9 aa] | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA-A2.1 HEAVY CHAIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | ERBB2_HUMAN GP2 PEPTIDE[9 aa] | D | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA-A2.1 HEAVY CHAIN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | gag peptide[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | O11822_9HIV1 GAG PROTEIN[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | O11822_9HIV1 GAG PROTEIN[9 aa] | D | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | W0GUW4_9HIV1 Gag protein[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | W0GUW4_9HIV1 Gag protein[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | O11803_9HIV1 Gag protein[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | W8EGN4_9HIV1 Gag protein[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GAG PEPTIDE[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV P17[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HIV P17[9 aa] | D | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | O11793_9HIV1 Gag protein[9 aa] | F | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | D | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | C | 79.2 /93.1 |
24 /24 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | A | 81.8 /93.1 |
22 /22 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PME17_HUMAN epitope of Melanocyte protein Pmel 17[9 aa] | D | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | A | 81.5 /93.1 |
27 /27 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | A | 84.6 /93.1 |
26 /26 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CRTC_HUMAN DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | CRTC_HUMAN DECAMERIC PEPTIDE FROM CALRETICULIN[10 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) (A.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1B[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1B[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1B[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1B[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Q6PIZ8_HUMAN T-cell Receptor, alpha chain[193 aa] | A | 75.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A2NVQ1_HUMAN T-Cell Receptor, Alpha Chain[194 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Q6PIZ8_HUMAN T-CELL RECEPTOR, ALPHA CHAIN[192 aa] | A | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A2NVQ1_HUMAN T-Cell Receptor, Alpha Chain[195 aa] | A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Transcriptional activator TAX[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Transcriptional activator TAX[9 aa] | D | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Modified HTLV-1 TAX (Y5K-IBA) peptide, chain C[9 a.. | A | 88.5 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6-Tcr[200 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6 TCR alpha chain[200 aa] | A | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6 TCR alpha chain[200 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6 TCR alpha chain[200 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6 TCR alpha chain[200 aa] | A | 92.3 /93.1 |
13 /13 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6 alpha chain[200 aa] | A | 91.7 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A6 alpha chain[200 aa] | A | 92.9 /93.1 |
14 /14 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melan-A/MART-1(26-35) peptide[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MAR1_HUMAN Melan-A/MART-1(26-35) peptide[10 aa] | D | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1 marker pe.. | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa] | A | 75.0 /93.1 |
24 /24 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[10 aa] | F | 76.0 /93.1 |
25 /25 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | D | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MAR1_HUMAN octapeptide from Melan-A/MART-1[9 aa] | D | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Peptide[9 aa] | A | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MAR1_HUMAN Peptide[9 aa] | D | 72.7 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MART-1(27-35) peptide[9 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MART-1(27-35) peptide[9 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Mart-1(27-35) peptide[9 aa] | A | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Mart-1(27-35) peptide[9 aa] | D | 72.7 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[9 aa] | A | 75.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL[9 aa] | A | 73.7 /93.1 |
19 /19 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a.. | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[6 a.. | D | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ENV_HV1MA ENVELOPE GLYCOPROTEIN GP160[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | ENV_HV1MA ENVELOPE GLYCOPROTEIN GP160[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | D | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | D | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | D | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | H5N1 INFLUENZA A NUCLEOPROTEIN[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PP65_HCMVA 65 KDA PHOSPHOPROTEIN[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE[9 a.. | D | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POF1B_HUMAN decameric peptide from Protein POF1B[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POF1B_HUMAN decameric peptide from Protein POF1B[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Modified HTLV-1 TAX (Y5(4fluoro)F) peptide[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Modified HTLV-1 TAX (Y5(3,4-difluoro)F) peptide[9 .. | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide 30-39 from beta-Catenin: YLDSGIHSGA[8 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | phospho-peptide 30-39 from beta-Catenin: YLD(Sep)G.. | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide 38-46 from cell division cycle 25b (CDC25b.. | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | phospho-peptide 38-46 from cell division cycle 25b.. | A | 86.4 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide 1097-1105 from insulin receptor substrate .. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | phospho-peptide 1097-1105 from insulin receptor s.. | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YYH6_9HIV1 HIV-1 peptide[10 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Q9YYH6_9HIV1 HIV-1 peptide[10 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NYESO-1 peptide[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | NYESO-1 peptide[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | CTG1B_HUMAN Cancer/testis antigen 1[9 aa] | F | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NY-ESO-1 peptide[9 aa] | A | 80.0 /93.1 |
25 /25 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | NY-ESO-1 peptide[9 aa] | G | 83.3 /93.1 |
24 /24 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Antibody light chain[206 aa] | A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | Antibody light chain[211 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | Antibody heavy chain[220 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | Antibody heavy chain[220 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | Heavy chain[214 aa] | A | 100.0 /93.1 |
1 /1 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Tel1p peptide[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Tel1p peptide[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Tel1p peptide[9 aa] | A | 88.9 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CANCER/MART-1[10 aa] | A | 80.0 /93.1 |
25 /25 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Mart-1 (26-35) peptide[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MART-1(27-35) peptide[10 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 80.8 /93.1 |
26 /26 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-CELL RECEPTOR, ALPHA CHAIN[194 aa] | A | 81.8 /93.1 |
11 /11 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF5 alpha chain[199 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF5 alpha chain[199 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF5 alpha chain[199 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Mel5 TCR chain alpha[194 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF5 TCR alpha chain[189 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TVAL2_HUMAN TCA_HUMAN DMF5 T-cell Receptor Alpha Chain fusion[192 aa] | A | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor alpha chain (TRAV/TRAC)[200 aa] | J | 71.4 /93.1 |
7 /7 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human T Cell Receptor Mel8, Alpha Chain[193 aa] | A | 88.9 /93.1 |
9 /9 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human T Cell Receptor Mel8, Alpha Chain[193 aa] | F | 75.0 /93.1 |
4 /4 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | Human T Cell Receptor Mel8, Alpha Chain[190 aa] | F | 88.9 /93.1 |
9 /9 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T-cell receptor alpha chain[199 aa] | D | 83.3 /93.1 |
12 /12 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | T-cell receptor alpha chain[198 aa] | I | 83.3 /93.1 |
12 /12 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell Receptor, Beta Chain[244 aa] | A | 100.0 /93.1 |
7 /7 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | High Affinity TCR Beta Chain[245 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Mel5 TCR chain beta[244 aa] | A | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | High Affinity Mel5 TCR, beta chain[244 aa] | A | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | WT1_HUMAN WT126 peptide[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | WT1_HUMAN WT126 peptide[9 aa] | D | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-MET-PHE-PRO-ASN-ALA-PRO-TYR-LEU[9 aa] | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VME1_CVHSA Membrane protein[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | VME1_CVHSA Membrane protein[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN NYESO-1 peptide analogue[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | CTG1B_HUMAN NYESO-1 peptide analogue[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 10-meric peptide from Hemagglutinin[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 10-meric peptide from Hemagglutinin[10 aa] | D | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 10-meric peptide from Hemagglutinin[10 aa] | G | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 10-meric peptide from Hemagglutinin[10 aa] | J | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q1WDM0_9INFA 10-meric peptide from Hemagglutinin[10 aa] | A | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Q1WDM0_9INFA 10-meric peptide from Hemagglutinin[10 aa] | D | 89.3 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | Q1WDM0_9INFA 10-meric peptide from Hemagglutinin[10 aa] | G | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | Q1WDM0_9INFA 10-meric peptide from Hemagglutinin[10 aa] | J | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | WT1_HUMAN Wilms tumor protein[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | WT1_HUMAN Wilms tumor protein[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptidomimetic ELA-1[8 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptidomimetic ELA-1[8 aa] | D | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptidomimetic ELA-2.1[8 aa] | A | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptidomimetic ELA-2.1[8 aa] | D | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptidomimetic ELA-1.1[8 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptidomimetic ELA-1.1[8 aa] | D | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptidomimetic ELA-2[8 aa] | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptidomimetic ELA-2[8 aa] | D | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | A7UMS0_EBVG BSLF2/BMLF1 protein[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-CELL RECEPTOR, ALPHA CHAIN[195 aa] | A | 81.8 /93.1 |
11 /11 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-CELL RECEPTOR, BETA CHAIN[245 aa] | A | 85.7 /93.1 |
7 /7 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PN45428 TCR beta chain[287 aa] | I | 66.7 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD (G2L,I9V) peptide[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HuD (G2L,I9V) peptide[9 aa] | D | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD peptide[9 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HuD peptide[9 aa] | D | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD peptide[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HuD (G2L) peptide[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HuD (G2L) peptide[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF5 beta chain[242 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF5 beta chain[242 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF5 beta chain[242 aa] | A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF5 TCR beta chain[242 aa] | A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | K7N5M4_HUMAN DMF5 beta chain,DMF5 beta chain[240 aa] | A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A0A1B0GXE1_HUMAN K7N5M4_HUMAN DMF5 T-cell Receptor Beta Chain fusion[242 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF4 alpha chain[195 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DMF4 alpha chain[194 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF4 beta chain[242 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF4 beta chain[243 aa] | A | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TAX(Y5F) peptide[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q692E0_CVHSA Md3-C9 peptide derived from Membrane glycoprotein[.. | A | 82.6 /93.1 |
23 /23 |
Q53Z42_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | INS_HUMAN Insulin[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | INS_HUMAN Insulin[10 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | INS_HUMAN Insulin[10 aa] | F | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[199 aa] | A | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[199 aa] | F | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[199 aa] | A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[199 aa] | F | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[189 aa] | A | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[191 aa] | F | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[197 aa] | A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[200 aa] | F | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[197 aa] | A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[197 aa] | F | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[197 aa] | A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[199 aa] | F | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 1E6 TCR Alpha Chain[199 aa] | A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 1E6 TCR Alpha Chain[200 aa] | F | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human T-cell Receptor, Class I, Light alpha Chain[.. | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | Human T-cell Receptor, Class I, Light alpha Chain[.. | F | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[244 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[245 aa] | F | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[246 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[246 aa] | F | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[244 aa] | A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[245 aa] | F | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[244 aa] | A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[246 aa] | F | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[246 aa] | A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[244 aa] | F | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[247 aa] | A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[244 aa] | F | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 1E6 TCR Beta Chain[247 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 1E6 TCR Beta Chain[247 aa] | F | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T-cell Receptor, Class I, Heavy beta Chain[2.. | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Human T-cell Receptor, Class I, Heavy beta Chain[2.. | F | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV peptide KVAELVHFL[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HIV peptide KVAELVHFL[9 aa] | D | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-based altered-peptide ligand KVAEIVHFL[9 aa] | A | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HIV-based altered-peptide ligand KVAEIVHFL[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-based altered-peptide ligand KVAELVWFL[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HIV-based altered-peptide ligand KVAELVWFL[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | E3GL_ADE06 Early E3 18.5 kDa glycoprotein[99 aa] | A | 93.3 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | E3GL_ADE06 Early E3 18.5 kDa glycoprotein[97 aa] | D | 100.0 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | FAT Cognate peptide[10 aa] | A | 78.3 /93.1 |
23 /23 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | FLT Cognate peptide[10 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | FLT Cognate peptide[10 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Immunogenic peptide[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Melanoma peptide[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | High Affinity TCR Alpha Chain[196 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | High Affinity Mel5 TCR, alpha chain[196 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | E1A heteroclitic Melanoma peptide[10 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | E1A heteroclitic Melanoma peptide[10 aa] | D | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | L8A heteroclitic Melanoma peptide[10 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Q9QAC5_HBV Core protein[9 aa] | D | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | BA | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | D | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | EA | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | G | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | HA | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | J | 75.0 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MA | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | KA | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | M | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | NA | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | P | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | S | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | V | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | NY-ESO1 DOUBLE MUTANT (1Y, 9V)[9 aa] | Y | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NY-ESO1 double mutant (1Y, 9V)[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | NY-ESO1 double mutant (1Y, 9V)[9 aa] | BA | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NY-ESO1 double mutant (1Y, 9V)[9 aa] | D | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | NY-ESO1 double mutant (1Y, 9V)[9 aa] | EA | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | NY-ESO1 double mutant (1Y, 9V)[9 aa] | G | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA | NY-ESO1 double mutant (1Y, 9V)[9 aa] | HA | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | NY-ESO1 double mutant (1Y, 9V)[9 aa] | J | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MA | NY-ESO1 double mutant (1Y, 9V)[9 aa] | KA | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | NY-ESO1 double mutant (1Y, 9V)[9 aa] | M | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA | NY-ESO1 double mutant (1Y, 9V)[9 aa] | NA | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | NY-ESO1 double mutant (1Y, 9V)[9 aa] | P | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | NY-ESO1 double mutant (1Y, 9V)[9 aa] | S | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | NY-ESO1 double mutant (1Y, 9V)[9 aa] | V | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | NY-ESO1 double mutant (1Y, 9V)[9 aa] | Y | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TERT_HUMAN Telomerase reverse transcriptase[9 aa] | A | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-LEU-ALA-LYS-PHE-LEU-HIS-TRP-LEU[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | H2RG00_PANTR K7N5M9_HUMAN Uncharacterized protein, T-cell receptor, sp3.4 al.. | A | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A0B4J277_HUMAN K7N5M3_HUMAN Protein TRAV22,Human nkt tcr alpha chain[200 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LSP1_HUMAN Lymphocyte-specific protein 1[12 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | AMPD2_HUMAN AMP deaminase 2[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | AZOBENZENE-CONTAINING PEPTIDE[6 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | AZOBENZENE-CONTAINING PEPTIDE[6 aa] | C | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MAR1_HUMAN Melanoma antigen recognized by T-cells 1[10 aa] | D | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ESK1[212 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | IMMUNOGLOBULIN HEAVY CHAIN[223 aa] | A | 77.8 /93.1 |
18 /18 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 77.8 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 77.3 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MVWGPDPLYV[10 aa] | A | 76.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 80.0 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Marker peptide[10 aa] | F | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Marker peptide[10 aa] | A | 76.9 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA[10 aa] | F | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLY-VAL-TRP-ILE-ARG-THR-PRO-PRO-ALA[9 aa] | A | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GP100 peptide YLEPGPVTA[9 aa] | A | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptide antigen YLAPGPVTA[9 aa] | A | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptide antigen YLAPGPVTA[9 aa] | D | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptide antigen YLEPAPVTA[9 aa] | A | 90.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL[9 aa] | A | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | PMEL_HUMAN Tumor-associated antigentic peptide gp100[9 aa] | F | 82.8 /93.1 |
29 /29 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human TCR Light Chain[204 aa] | A | 71.4 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human TCR Heavy Chain[244 aa] | A | 90.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | M1-G4E, GILEFVFTL[9 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCRalpha chain[200 aa] | A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCRalpha chain[201 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | TCRalpha chain[203 aa] | F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-LEU-ALA-LYS-PHE-LEU-HIS-THR-LEU[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-LEU-ALA-LYS-PHE-LEU-HIS-GLU-LEU[9 aa] | A | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | W8FN10_9FLAV NS5[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | W8FN10_9FLAV NS5[9 aa] | D | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | T-cell receptor Alpha chain[200 aa] | F | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | HUman T-cell receptor Alpha chain[200 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human T-cell receptor alpha chain[200 aa] | A | 81.8 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Human T-cell receptor beta chain[241 aa] | F | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T-cell receptor Beta chain[239 aa] | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T-cell Receptor beta chain[242 aa] | A | 88.9 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR F50 alpha chain[202 aa] | B | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR F50 beta chain[240 aa] | B | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T cell receptor alpha chain[192 aa] | C | 77.8 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T cell receptor alpha chain[191 aa] | E | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T cell receptor alpha chain[190 aa] | G | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T cell receptor beta chain[241 aa] | C | 100.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor beta chain[242 aa] | E | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T cell receptor beta chain[239 aa] | G | 100.0 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | NS3 peptide[10 aa] | C | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa] | E | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | LYS-LEU-VAL-ALA-LEU-GLY-ILE-ASN-ALA-VAL[10 aa] | G | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SER-MET-LEU-GLY-ILE-GLY-ILE-VAL-PRO-VAL[10 aa] | A | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | K7N5M3_HUMAN DMF5 alpha chain,DMF5 alpha chain[185 aa] | A | 83.3 /93.1 |
12 /12 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Q6PJ56_HUMAN Q6PJ56_HUMAN TRA@ protein[198 aa] | A | 87.5 /93.1 |
8 /12 |
B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMER.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T-CELL RECEPTOR GAMMA VARIABLE 8,T-CELL RECEPTOR G.. | A | 87.5 /93.1 |
8 /9 |
B2MG_HUMAN 1A02_HUMAN MART1 PEPTIDE-BETA-2-MICROGLOBULIN-HLA-A*02 CHIMER.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | D9IDM8_HUMAN LIR-1[169 aa] | A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RETR2_HUMAN Reticulophagy regulator 2[9 aa] | A | 82.8 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SYNEM_HUMAN Synemin[9 aa] | A | 85.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa] | A | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | MET-THR-SER-ALA-ILE-GLY-ILE-LEU-PRO-VAL[10 aa] | D | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ILE-THR-SER-GLY-ILE-GLY-VAL-LEU-PRO-VAL[10 aa] | A | 80.0 /93.1 |
20 /20 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | RTA_EBVG Replication and transcription activator[9 aa] | AB | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RTA_EBVG Replication and transcription activator[9 aa] | BA | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RTA_EBVG Replication and transcription activator[9 aa] | CA | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RTA_EBVG Replication and transcription activator[9 aa] | CB | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | RTA_EBVG Replication and transcription activator[9 aa] | EA | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | RTA_EBVG Replication and transcription activator[9 aa] | EB | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | RTA_EBVG Replication and transcription activator[9 aa] | GA | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | RTA_EBVG Replication and transcription activator[9 aa] | IA | 81.0 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RTA_EBVG Replication and transcription activator[9 aa] | KA | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | RTA_EBVG Replication and transcription activator[9 aa] | MA | 78.3 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RTA_EBVG Replication and transcription activator[9 aa] | OA | 87.0 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GB | RTA_EBVG Replication and transcription activator[9 aa] | QA | 80.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | RTA_EBVG Replication and transcription activator[9 aa] | SA | 83.3 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | RTA_EBVG Replication and transcription activator[9 aa] | T | 79.2 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | RTA_EBVG Replication and transcription activator[9 aa] | UA | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | RTA_EBVG Replication and transcription activator[9 aa] | V | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | RTA_EBVG Replication and transcription activator[9 aa] | WA | 81.8 /93.1 |
22 /22 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | RTA_EBVG Replication and transcription activator[9 aa] | X | 90.5 /93.1 |
21 /21 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | RTA_EBVG Replication and transcription activator[9 aa] | YA | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | RTA_EBVG Replication and transcription activator[9 aa] | Z | 82.6 /93.1 |
23 /23 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Melanoma antigen variant[9 aa] | A | 85.2 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | A | 80.8 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | D | 84.0 /93.1 |
25 /25 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | A | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | D | 81.5 /93.1 |
27 /27 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | G | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | HAUS3_HUMAN HAUS augmin-like complex subunit 3[9 aa] | J | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SER-LEU-SER-LYS-ILE-LEU-ASP-THR-VAL[9 aa] | A | 87.5 /93.1 |
24 /24 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TVA22_HUMAN K7N5M3_HUMAN T cell receptor alpha variable 22,Human nkt tcr al.. | A | 80.0 /93.1 |
15 /15 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TVBK2_HUMAN K7N5M4_HUMAN T cell receptor beta variable 11-2,Human nkt tcr b.. | A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-cell receptor alpha chain[197 aa] | A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | T-cell receptor alpha chain[198 aa] | F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T4H2 T cell receptor alpha chain[201 aa] | A | 81.8 /93.1 |
11 /11 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T4H2 T cell receptor alpha chain[201 aa] | A | 81.8 /93.1 |
11 /11 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T4H2 T cell receptor alpha chain[201 aa] | C | 83.3 /93.1 |
12 /12 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell receptor beta chain[244 aa] | A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | T-cell receptor beta chain[244 aa] | F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | a7b2 ALPHA CHAIN[192 aa] | A | 80.0 /93.1 |
10 /10 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DMF4 Beta CHAIN[242 aa] | A | 100.0 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Human T-cell Receptor YLQ36, beta chain[242 aa] | A | 88.9 /93.1 |
9 /9 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Human T-cell Receptor YLQ36, beta chain[242 aa] | F | 90.0 /93.1 |
10 /10 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa] | A | 79.3 /93.1 |
29 /29 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-TRP-ALA-GLY-PRO-MET-ALA-VAL[9 aa] | D | 85.7 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa] | A | 78.6 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-TRP-ASN-GLY-PRO-ILE-ALA-VAL[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa] | A | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-TRP-ASN-GLY-PRO-MET-HIS-VAL[9 aa] | D | 84.6 /93.1 |
26 /26 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa] | D | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | LEU-LEU-TRP-ASN-GLY-PRO-MET-GLN-VAL[9 aa] | J | 82.1 /93.1 |
28 /28 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | T cell receptor, alpha chain[108 aa] | A | 100.0 /93.1 |
9 /9 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | T cell receptor, alpha chain[110 aa] | D | 100.0 /93.1 |
12 /12 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | T cell receptor, beta chain[112 aa] | A | 83.3 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | T cell receptor, beta chain[114 aa] | D | 85.7 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SILv44 T cell receptor alpha chain[197 aa] | C | 71.4 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SILv44 T cell receptor alpha chain[196 aa] | A | 80.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PMEL_HUMAN Melanocyte protein PMEL[9 aa] | C | 82.8 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | C | 89.3 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | C | 88.9 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | J | 88.0 /93.1 |
25 /25 |
U5YKE0_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | A | 88.0 /93.1 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | F | 88.5 /93.1 |
26 /26 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | K | 85.2 /93.1 |
27 /27 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | P53_HUMAN Cellular tumor antigen p53 peptide[9 aa] | P | 88.5 /93.1 |
26 /26 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | Immunoglobulin heavy chain H2[222 aa] | J | 83.3 /93.1 |
6 /6 |
U5YKE0_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa] | A | 87.5 /93.1 |
24 /24 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-GLY-TRP-VAL-PHE-ALA-GLN-VAL[9 aa] | D | 84.6 /93.1 |
26 /26 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-SER-TUR-PHE-GLY-THR-PRO-THR[9 aa] | D | 86.4 /93.1 |
22 /22 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 T-cell Epitope S1[9 aa] | A | 84.0 /93.1 |
25 /25 |
A0A5H2UU57_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | SARS-CoV-2 T-cell Epitope S1[9 aa] | D | 80.0 /93.1 |
25 /25 |
A0A5H2UU57_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1 peptide[10 aa] | A | 80.0 /93.1 |
30 /30 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 76.0 /93.1 |
25 /25 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 80.8 /93.1 |
26 /26 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IBPL1_HUMAN Insulin-like growth factor-binding protein-like 1 .. | A | 87.0 /93.1 |
23 /23 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 77.8 /93.1 |
27 /27 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 79.3 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | SPIKE_SARS2 Spike protein S1[9 aa] | D | 78.6 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | SPIKE_SARS2 Spike protein S1[9 aa] | G | 77.8 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | SPIKE_SARS2 Spike protein S1[9 aa] | J | 78.6 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1[9 aa] | A | 80.8 /93.1 |
26 /26 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | SPIKE_SARS2 Spike protein S1[9 aa] | F | 81.5 /93.1 |
27 /27 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Human T-cell Receptor YLQ36, alpha chain[199 aa] | A | 85.7 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | Human T-cell Receptor YLQ36, alpha chain[199 aa] | F | 83.3 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | T-cell receptor beta chain (TRBV/TRBC)[238 aa] | J | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | MAGAA_HUMAN Melanoma-associated antigen 10[9 aa] | J | 80.8 /93.1 |
26 /26 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | T-cell receptor alpha chain[243 aa] | F | 83.3 /93.1 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa] | D | 81.5 /93.1 |
27 /27 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | ASN-LEU-SER-ALA-LEU-GLY-ILE-PHE-SER-THR[10 aa] | M | 83.3 /93.1 |
30 /30 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Fab heavy chain[212 aa] | E | 80.0 /93.1 |
10 /10 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Fab heavy chain[218 aa] | G | 77.8 /93.1 |
9 /9 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Fab light chain[211 aa] | E | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Fab light chain[211 aa] | G | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | E | 82.8 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | G | 82.8 /93.1 |
29 /29 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | A | 82.8 /93.1 |
29 /29 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | PHE-MET-ASN-LYS-PHE-ILE-TYR-GLU-ILE[9 aa] | E | 84.0 /93.1 |
25 /25 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 6-11 T cell receptor alpha chain[200 aa] | A | 100.0 /93.1 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 6-11 T cell receptor alpha chain[200 aa] | F | 100.0 /93.1 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | 6-11 T cell receptor alpha chain[200 aa] | K | 100.0 /93.1 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | 6-11 T cell receptor alpha chain[200 aa] | P | 100.0 /93.1 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | I27RA_HUMAN Interleukin-27 receptor subunit alpha[17 aa] | A | 80.6 /93.1 |
31 /31 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | I27RA_HUMAN Interleukin-27 receptor subunit alpha[16 aa] | C | 77.8 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Light chain[211 aa] | A | 90.0 /93.1 |
10 /10 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' peptide [9 aa] | A | 86.2 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PGM5 peptide (465-473) (H5Y)[9 aa] | A | 78.9 /93.1 |
19 /19 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | PGM5 peptide (465-473) (H5Y)[9 aa] | D | 76.2 /93.1 |
21 /21 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 Spike-derived peptide S417-425 K417T mu.. | A | 75.9 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLG.. | A | 81.8 /93.1 |
22 /22 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | LEU-LEU-LEU-GLY-ILE-GLY-ILE-LEU-VAL[9 aa] | D | 78.6 /93.1 |
28 /28 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | T-cell receptor beta chain[242 aa] | D | 100.0 /93.1 |
5 /5 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | T-cell receptor beta chain[242 aa] | I | 100.0 /93.1 |
2 /2 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | D | 82.8 /93.1 |
29 /29 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | NCAP_SARS2 Nucleoprotein[9 aa] | I | 82.1 /93.1 |
28 /28 |
U5YKE0_HUMAN MHC class I antigen alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | PA2.1 Fab Heavy Chain[215 aa] | A | 83.3 /93.1 |
12 /12 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | PA2.1 Fab Heavy Chain[215 aa] | G | 90.0 /93.1 |
10 /10 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | PA2.1 Fab Light Chain[217 aa] | A | 66.7 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | PA2.1 Fab Light Chain[217 aa] | G | 75.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | PN45545 TCR alpha chain[257 aa] | I | 81.8 /93.1 |
11 /11 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | PN45545 TCR beta chain[287 aa] | I | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | PN45428 TCR alpha chain[251 aa] | I | 100.0 /93.1 |
7 /7 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TLF: TLFDEPPPL[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2[9 aa] | A | 85.2 /93.1 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SARS-CoV-2 specific private TCR RLQ7 alpha[191 aa].. | A | 80.0 /93.1 |
10 /10 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SARS-CoV-2 specific private TCR RLQ7 alpha[190 aa].. | A | 88.9 /93.1 |
9 /9 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SARS-CoV-2 specific private TCR RLQ7 beta[244 aa] | A | 100.0 /93.1 |
11 /11 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SARS-CoV-2 specific private TCR RLQ7 beta[245 aa] | A | 100.0 /93.1 |
9 /9 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2[9 aa] | A | 82.1 /93.1 |
28 /28 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Sorting nexin 24 (127-135)(P132L) peptide[9 aa] | A | 80.8 /93.1 |
26 /26 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Sorting nexin 24 (127-135)(P132L) peptide[9 aa] | D | 83.3 /93.1 |
24 /24 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Sorting nexin 24 (127-135)(P132L) peptide[9 aa] | A | 80.0 /93.1 |
25 /25 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Sorting nexin 24 (127-135)(P132L) peptide[9 aa] | C | 82.8 /93.1 |
29 /29 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Sorting nexin 24 (127-135) peptide[9 aa] | A | 83.3 /93.1 |
24 /24 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Sorting nexin 24 (127-135) peptide[9 aa] | D | 85.2 /93.1 |
27 /27 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' peptide VVFLHVTYV [9 aa] | A | 80.8 /92.8 |
26 /26 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' peptide VLNDILSRL [9 aa] | A | 85.2 /92.8 |
27 /27 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 80.0 /92.4 |
25 /25 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[9 aa] | A | 77.8 /92.4 |
27 /27 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS2 Nucleoprotein[3 aa] | A | 86.7 /92.4 |
15 /15 |
Q861F7_HUMAN MHC class I antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ARG
|
A | 100.0 /94.1 |
11 /11 |
1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68.1) |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
3IB
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
TAM
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NA
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NA
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NA
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
NA
|
D | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
A | 66.7 /92.4 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NA
|
A | 100.0 /92.4 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NA
|
A | 100.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /92.4 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /97.5 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
NA
|
A | 100.0 /94.2 |
3 /3 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
NA
|
C | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /93.1 |
1 /1 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
NA
|
A | 100.0 /97.5 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
NA
|
E | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
CL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
YB |
CL
|
BA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
CL
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
CL
|
G | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
FC |
CL
|
HA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
BB |
CL
|
J | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
HC |
CL
|
KA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EB |
CL
|
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
CL
|
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
CL
|
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
JB |
CL
|
P | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
QB |
CL
|
V | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UB |
CL
|
Y | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
VB |
CL
|
Y | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
CL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA |
CL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EC |
CL
|
BA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
CL
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
IC |
CL
|
EA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
JC |
CL
|
EA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
LC |
CL
|
HA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
MC |
CL
|
HA | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
CL
|
M | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
HB |
CL
|
M | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IB |
CL
|
M | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JB |
CL
|
M | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
MB |
CL
|
P | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
QB |
CL
|
S | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RB |
CL
|
S | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
UB |
CL
|
V | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
YB |
CL
|
Y | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
CL
|
A | 50.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CL
|
D | 50.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CL
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /97.5 |
3 /3 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CL
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
CL
|
C | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
CL
|
E | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
CL
|
E | 83.3 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MG
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() |
![]() |
E |
MG
|
A | 100.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MG
|
D | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MG
|
A | 33.3 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
C | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
A | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MG
|
A | 50.0 /94.2 |
2 /2 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NI
|
A | 0.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NI
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
IOD
|
A | 100.0 /94.2 |
3 /3 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 0.0 /92.4 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /92.4 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /92.4 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /92.8 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /92.8 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /92.8 |
2 /2 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CD
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CD
|
A | 0.0 /93.1 |
1 /1 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
BR
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
CA
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
3NI
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
3NI
|
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ZN
|
A | 100.0 /92.8 |
2 /2 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 100.0 /93.1 |
2 /2 |
Q53Z42_HUMAN HLA class I antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-.. | D | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | A | 90.9 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. | A | 90.9 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | A | 100.0 /97.5 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | C | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | C | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | E | 100.0 /97.5 |
7 /7 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[275 aa] | E | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[274 aa] | A | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | A | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | C | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | C | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q5S3G3_HUMAN HLA class I histocompatibility antigen[273 aa] | E | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q5S3G3_HUMAN HLA class I histocompatibility antigen[274 aa] | E | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
365 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
IMD
|
C | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
IMD
|
A | 100.0 /99.6 |
7 /7 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
IMD
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 66.7 /97.5 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /97.5 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /93.1 |
5 /5 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
1 /1 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 0.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 66.7 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /94.5 |
6 /6 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 71.4 /94.5 |
7 /7 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /94.5 |
3 /3 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /94.5 |
1 /1 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /94.5 |
1 /1 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /94.5 |
3 /3 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /94.5 |
2 /2 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
SO4
|
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA |
SO4
|
F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
SO4
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
UA |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
V |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EB |
SO4
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
SO4
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
SO4
|
F | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
SO4
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
SO4
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
W |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
SO4
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /94.2 |
4 /4 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /94.2 |
2 /2 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
SO4
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
SO4
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
SO4
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
SO4
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
V |
SO4
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
D | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
D | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /97.5 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
D | 100.0 /97.5 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
G | 100.0 /97.4 |
3 /3 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
G | 100.0 /97.4 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
J | 100.0 /97.4 |
2 /2 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /97.4 |
4 /4 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 0.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
SO4
|
F | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
SO4
|
D | 66.7 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
SO4
|
D | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
SO4
|
D | 100.0 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
SO4
|
D | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
SO4
|
D | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
SO4
|
D | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
SO4
|
D | 50.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
SO4
|
D | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
D | 100.0 /97.5 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 50.0 /97.4 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /94.2 |
5 /5 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /94.2 |
2 /2 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
C | 100.0 /94.2 |
1 /1 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
SO4
|
C | 100.0 /94.2 |
2 /2 |
B0UXQ0_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
D | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
D | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
SO4
|
D | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
SO4
|
A | 100.0 /100.0 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
SO4
|
A | 100.0 /100.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
SO4
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
SO4
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
SO4
|
A | 100.0 /97.5 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
V |
EDO
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EDO
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
EDO
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
EDO
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
F | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
EDO
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
EDO
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
F | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
EDO
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
HA |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
SA |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AB |
EDO
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BB |
EDO
|
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
CB |
EDO
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HB |
EDO
|
F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IB |
EDO
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
JB |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
LB |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
SB |
EDO
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WA |
EDO
|
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
XA |
EDO
|
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
EDO
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
ZA |
EDO
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
EDO
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
EDO
|
F | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
EDO
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
EDO
|
F | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
F | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
EDO
|
F | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA |
EDO
|
F | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA |
EDO
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
D | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
EDO
|
A | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
MA |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
EDO
|
A | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
EDO
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
EDO
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
EDO
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
EDO
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
EDO
|
A | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /94.2 |
4 /4 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /94.2 |
3 /3 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /94.2 |
1 /1 |
1A68_HUMAN HLA class I histocompatibility antigen, A-68 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /99.6 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
D | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
EDO
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
EDO
|
J | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
D | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
D | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
D | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
G | 100.0 /93.1 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
EDO
|
G | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EDO
|
G | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
G | 100.0 /93.1 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
EDO
|
G | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
EDO
|
J | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
EDO
|
J | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
EDO
|
J | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
EDO
|
J | 83.3 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
D | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
EDO
|
M | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 100.0 /93.1 |
1 /1 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
F | 100.0 /93.1 |
2 /2 |
U5YJM1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
D | 100.0 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
D | 85.7 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EDO
|
A | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /97.5 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EDO
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
E | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /97.4 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EDO
|
A | 75.0 /97.4 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EDO
|
A | 66.7 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /97.4 |
6 /6 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
EDO
|
C | 87.5 /97.4 |
8 /8 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
EDO
|
C | 100.0 /97.4 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EDO
|
C | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
EDO
|
C | 100.0 /97.4 |
1 /1 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
EDO
|
C | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
EDO
|
C | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
EDO
|
E | 100.0 /97.4 |
5 /5 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
EDO
|
E | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
EDO
|
E | 100.0 /97.4 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ALA
|
A | 100.0 /94.1 |
2 /2 |
1A68_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-AW68.1) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ACT
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 66.7 /92.4 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 50.0 /92.4 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ACT
|
A | 100.0 /92.4 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ACT
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 66.7 /92.8 |
3 /3 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ACT
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ACT
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
1PG
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
1PG
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
D | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
D | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
D | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
GOL
|
D | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
GOL
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
D | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
GOL
|
D | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /94.5 |
5 /5 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /94.5 |
2 /2 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.5 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /97.5 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.5 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /97.5 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 80.0 /97.5 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /97.5 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /94.5 |
7 /7 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /94.5 |
6 /6 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 50.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
2 /2 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 33.3 /93.1 |
3 /3 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
A | 100.0 /93.1 |
1 /1 |
Q8WLS4_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 83.3 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
D | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 87.5 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BC |
GOL
|
BA | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
ZB |
GOL
|
BA | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UA |
GOL
|
D | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
XA |
GOL
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EC |
GOL
|
EA | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
ZA |
GOL
|
G | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GC |
GOL
|
HA | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DB |
GOL
|
J | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IC |
GOL
|
KA | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KC |
GOL
|
KA | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IB |
GOL
|
M | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MC |
GOL
|
NA | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KB |
GOL
|
P | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MB |
GOL
|
P | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PB |
GOL
|
S | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RB |
GOL
|
V | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
SB |
GOL
|
V | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WB |
GOL
|
Y | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
SA |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FC |
GOL
|
BA | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GC |
GOL
|
BA | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WA |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
XA |
GOL
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
ZA |
GOL
|
D | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KC |
GOL
|
EA | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CB |
GOL
|
G | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OC |
GOL
|
HA | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
GOL
|
J | 33.3 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QC |
GOL
|
KA | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RC |
GOL
|
KA | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LB |
GOL
|
M | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UC |
GOL
|
NA | 25.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NB |
GOL
|
P | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PB |
GOL
|
P | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TB |
GOL
|
S | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VB |
GOL
|
V | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WB |
GOL
|
V | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DC |
GOL
|
Y | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /94.5 |
2 /2 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
GOL
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
F | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
GOL
|
F | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
GOL
|
F | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
GOL
|
F | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
GOL
|
F | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DB |
GOL
|
F | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
GOL
|
F | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA |
GOL
|
F | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 50.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
GOL
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
GOL
|
A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
F | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 75.0 /97.4 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /97.4 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /97.4 |
1 /1 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
E | 50.0 /97.5 |
2 /2 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
E | 100.0 /97.5 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
6 /6 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /97.4 |
1 /1 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.4 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /97.4 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /97.4 |
3 /3 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /97.4 |
5 /5 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
D | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
G | 66.7 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
GOL
|
G | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
GOL
|
G | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
GOL
|
J | 40.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
GOL
|
J | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
GOL
|
J | 60.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
GOL
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
T |
GOL
|
D | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
GOL
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
GOL
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
A | 66.7 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
GOL
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
GOL
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
GOL
|
J | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
GOL
|
J | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
C | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
C | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
C | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /100.0 |
2 /2 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /97.5 |
3 /3 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
GOL
|
E | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
GOL
|
G | 66.7 /93.1 |
3 /3 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /100.0 |
5 /5 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
GOL
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
GOL
|
A | 100.0 /100.0 |
1 /1 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GOL
|
A | 66.7 /93.1 |
6 /6 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
5 /5 |
HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
A | 100.0 /93.1 |
5 /5 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
A | 100.0 /93.1 |
5 /5 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
C | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
FMT
|
A | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
FMT
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
FMT
|
D | 50.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
FMT
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
FMT
|
D | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
FMT
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
FMT
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
FMT
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
FMT
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA-A*0201 heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
FMT
|
A | 100.0 /100.0 |
4 /4 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
FMT
|
A | 100.0 /100.0 |
3 /3 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
FMT
|
G | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
IPA
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
IPA
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
IPA
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
IPA
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
IPA
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
IPA
|
C | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
IPA
|
C | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PGE
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
PGE
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
PGE
|
G | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PGE
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PGE
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
PGE
|
A | 57.1 /93.1 |
7 /7 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
PGE
|
E | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
PGE
|
E | 66.7 /93.1 |
6 /6 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
PGE
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
7PE
|
A | 100.0 /93.1 |
11 /11 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MES
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MES
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MES
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MES
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MES
|
D | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MES
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MES
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MES
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MES
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MES
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MES
|
D | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MES
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MES
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MES
|
A | 85.7 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MES
|
A | 50.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
MES
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MES
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
MES
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
MES
|
A | 100.0 /99.6 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
MES
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MES
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
MES
|
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
MES
|
D | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MES
|
C | 66.7 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PG4
|
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
PG4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA |
PG4
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
PG4
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
HA |
PG4
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
PG4
|
A | 80.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
PG4
|
A | 100.0 /93.1 |
9 /9 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
PG4
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
PG4
|
A | 100.0 /93.1 |
8 /8 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PG4
|
A | 100.0 /99.6 |
2 /2 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PG4
|
A | 100.0 /99.6 |
6 /6 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PG4
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PG4
|
E | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
PG4
|
E | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z |
PG4
|
G | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
PG4
|
A | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
PG4
|
A | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
ACY
|
A | 0.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
ACY
|
A | 100.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
EPE
|
A | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EPE
|
D | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EPE
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EPE
|
A | 75.0 /93.1 |
4 /4 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EPE
|
E | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EPE
|
E | 100.0 /93.1 |
2 /2 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
EPE
|
G | 100.0 /93.1 |
1 /1 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
PEG
|
A | 100.0 /93.1 |
7 /7 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PEG
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
PEG
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
PEG
|
A | 100.0 /97.4 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
PEG
|
A | 100.0 /97.4 |
3 /3 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
E | 83.3 /97.5 |
6 /6 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
PEG
|
E | 100.0 /97.5 |
5 /5 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
PEG
|
E | 100.0 /97.5 |
2 /2 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PEG
|
A | 100.0 /99.6 |
5 /5 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
PEG
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
A | 100.0 /99.6 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
PEG
|
A | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
A | 100.0 /93.1 |
1 /1 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
PEG
|
D | 100.0 /93.1 |
5 /5 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PEG
|
A | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
PEG
|
A | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
PEG
|
D | 100.0 /93.1 |
6 /6 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
PEG
|
J | 100.0 /93.1 |
3 /3 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PEG
|
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
PEG
|
F | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
PEG
|
D | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
W |
PEG
|
D | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
PEG
|
D | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
AB |
PEG
|
M | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
ZA |
PEG
|
M | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
PEG
|
A | 100.0 /93.1 |
4 /4 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
A | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PEG
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
PEG
|
A | 100.0 /93.1 |
2 /2 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
PEG
|
E | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
PEG
|
E | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
PEG
|
E | 80.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
PEG
|
E | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PEG
|
A | 100.0 /100.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PEG
|
A | 100.0 /97.5 |
2 /2 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
PEG
|
E | 100.0 /97.5 |
4 /4 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
PEG
|
C | 100.0 /97.4 |
3 /3 |
Q5S3G3_HUMAN HLA class I histocompatibility antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PEG
|
A | 100.0 /93.1 |
5 /5 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
PEG
|
A | 100.0 /93.1 |
3 /3 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
P4G
|
D | 100.0 /93.1 |
2 /2 |
1A02_HUMAN HLA class I histocompatibility antigen, A-2 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
FLC
|
A | 100.0 /93.1 |
1 /1 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
PO4
|
J | 100.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
P6G
|
E | 100.0 /93.1 |
5 /5 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
1PE
|
G | 100.0 /93.1 |
6 /6 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
1PE
|
A | 100.0 /93.1 |
3 /3 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
1PE
|
E | 100.0 /93.1 |
5 /5 |
A0A5B8RNS7_HUMAN MHC class I antigen, A-2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
TRS
|
A | 75.0 /93.1 |
4 /4 |
Q861F7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NO3
|
A | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NO3
|
D | 100.0 /93.1 |
4 /4 |
Q53Z42_HUMAN HLA-A*02:01 alpha chain |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |